EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of prostaglandin F2 analog treatment on proliferation and MAPK/ERK signaling in conjunctival tissues of glaucoma patients

Filip Kelava, Marin Ogorevc

ST-OPEN · 12.03.2026 · 7 · 1-10

DOI: 10.48188/so.7.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ST-OPEN, online erschienen am 12.03.2026. Verfasst von Filip Kelava und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To compare the proliferation and activation of the MAPK/ERK signaling pathway in conjunctival cells between glaucoma patients treated with prostaglandin F2 (PGF2) analogs and those who did not receive PGF2 analog treatment. We hypothesized that PGF2 analog treatment increases both processes.

Methods

We conducted a retrospective cross-sectional study at the University Hospital of Split on conjunctival samples collected from PGF2-treated (PGF2-T) glaucoma patients (n = 6) and non-treated (PGF2-NT) patients (n = 4). Samples were stained for Ki-67 and phospho-ERK1/2 using immunofluorescence methods. We analyzed data using independent samples t-tests, with the significance threshold set at an α of 0.05 (P < 0.05).

Results

The proliferation marker Ki-67 and P-ERK1/2, a marker of MAPK/ERK activation, were expressed in both epithelial and stromal cells of the conjunctival tissues in glaucoma patients. Ki-67 expression was significantly higher in the conjunctival tissues of the PGF2-T group (mean (x̄) = 8.40%, standard deviation (SD) = 1.30%, P = 0.0007) compared to the PGF2-NT group (x̄ = 4.25%, SD = 1.04%). Similarly, P-ERK1/2 expression in conjunctival tissues was significantly higher in the PGF2-T group (x̄ = 17.29%, SD = 2.39%, P = 0.0094) compared to the PGF2-NT group (x̄ = 11.93%, SD = 2.53%).

Conclusions

Treatment with PGF2 analogs increases cellular proliferation and activates the MAPK/ERK signaling pathway in conjunctival tissues of glaucoma patients. This may help explain the adverse effects of these drugs. Future studies should investigate the role of MAPK/ERK signaling in conjunctival tissues and alternative pathways affected by PGF2 analogs, which may help improve glaucoma therapy and reduce adverse effects.

Zitieren

APA

Kelava, F., & Ogorevc, M. (2026). Effect of prostaglandin F2 analog treatment on proliferation and MAPK/ERK signaling in conjunctival tissues of glaucoma patients. ST-OPEN, 7, 1-10. https://doi.org/10.48188/so.7.3

Vancouver

Kelava F, Ogorevc M. Effect of prostaglandin F2 analog treatment on proliferation and MAPK/ERK signaling in conjunctival tissues of glaucoma patients. ST-OPEN. 2026;7:1-10. doi:10.48188/so.7.3

BibTeX
@article{Kelava2026,
  author = {Kelava, Filip and Ogorevc, Marin},
  title = {Effect of prostaglandin F2 analog treatment on proliferation and MAPK/ERK signaling in conjunctival tissues of glaucoma patients},
  journal = {ST-OPEN},
  year = {2026},
  volume = {7},
  pages = {1--10},
  doi = {10.48188/so.7.3}
}
Kostenlos starten →